HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice.

Abstract
Flavone-8-acetic acid plus recombinant human interleukin 2 is a successful antitumor therapy in mice bearing the Renca murine renal cell carcinoma. This report demonstrates that T cells, particularly CD8+ T cells, are critical for the generation of this response. Initial experiments examining T-cell signal transduction proteins demonstrated that T cells from Renca-bearing mice had undetectable levels of p56lck and zeta-chain of the T-cell receptor and that flavone-8-acetic acid and recombinant human interleukin 2 therapy could be used as a model for reversal of these alterations. However, further experimentation showed that the majority of the reduction in zeta-chain and part of the reduction in p56lck was due to degradation of these molecules during protein extraction caused by mature granulocytes contaminating the enriched T-cell population. This was not the case for nuclear c-Rel or NF kappa B p65, which remained at undetectable/reduced levels in the absence of granulocytes, confirming our previous data that transcription factor alterations exist in tumor-bearing mice. Thus, most of the reduction in zeta-chain in T cells from Renca-bearing mice is due to granulocyte contamination and emphasizes the need to use pure T-cell populations and/or sufficient amounts and types of protease inhibitors when quantitating proteins in T cells from tumor-bearing mice.
AuthorsJ L Franco, P Ghosh, R H Wiltrout, C R Carter, A H Zea, N Momozaki, A C Ochoa, D L Longo, T J Sayers, K L Komschlies
JournalCancer research (Cancer Res) Vol. 55 Issue 17 Pg. 3840-6 (Sep 01 1995) ISSN: 0008-5472 [Print] United States
PMID7641202 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Flavonoids
  • Interleukin-2
  • Receptors, Antigen, T-Cell
  • flavone acetic acid
  • Protein-Tyrosine Kinases
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • CD4-Positive T-Lymphocytes (chemistry, immunology)
  • CD8-Positive T-Lymphocytes (chemistry, immunology)
  • Carcinoma, Renal Cell (immunology, therapy)
  • Flavonoids (therapeutic use)
  • Granulocytes (immunology)
  • Immunotherapy
  • Interleukin-2 (therapeutic use)
  • Kidney Neoplasms (immunology, therapy)
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  • Mice
  • Mice, Inbred BALB C
  • Protein-Tyrosine Kinases (analysis)
  • Receptors, Antigen, T-Cell (analysis)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: